Related Experiment Video
Updated: Sep 16, 2025

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Causal Inference and Shared Molecular Pathways in Crohn's Disease, Celiac Disease, and Ankylosing Spondylitis:
Ya Li1, Shihao Xu1, Mingzhu Zhang1
1First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
Insights
This study found shared genetic links between Crohn's disease, celiac disease, and ankylosing spondylitis. Identifying common immune genes offers new therapeutic targets for these inflammatory conditions.
Area of Science:
- Genetics and Immunology
- Gastroenterology and Rheumatology
Background:
- Crohn's disease (CD), celiac disease (CeD), and ankylosing spondylitis (AS) are distinct inflammatory conditions.
- Understanding their shared underlying mechanisms is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the causal and molecular overlap between CD, CeD, and AS.
- To identify shared genetic factors and immune pathways implicated in these diseases.
- To explore potential cross-disease therapeutic targets.
Main Methods:
- Bidirectional Mendelian randomization was employed to assess causal relationships between disease pairs.
- Transcriptomic analyses identified key upregulated genes across all three conditions.
- Independent datasets and inflammatory cell models were used for validation.
- Functional enrichment, regulatory network, and molecular docking analyses were performed.
Main Results:
- Significant bidirectional causal associations were found between each pair of diseases (CD-CeD, CD-AS, CeD-AS).
- Three hub genes (P2RY8, ITGAL, GPR65) were consistently upregulated across all conditions and validated.
- These genes are implicated in immune signaling and mucosal inflammation.
- Trichostatin A emerged as a potential therapeutic agent through network and docking analyses.
Conclusions:
- Shared genetic and immune-related mechanisms underlie CD, CeD, and AS.
- The identified hub genes represent potential therapeutic targets for cross-disease treatment strategies.
- This research provides a foundation for novel therapeutic approaches targeting common pathways in these inflammatory diseases.
Abstract:
This study explored the causal and molecular overlap among Crohn's disease (CD), celiac disease (CeD), and ankylosing spondylitis (AS). Bidirectional Mendelian randomization revealed significant causal associations between each disease pair. Transcriptomic analyses identified three consistently upregulated hub genes-P2RY8, ITGAL, and GPR65-across all conditions, which were validated in independent datasets and inflammatory cell models. Functional enrichment suggested these genes are involved in immune signaling and mucosal inflammation. Regulatory network and molecular docking analyses further highlighted Trichostatin A as a potential therapeutic agent. These findings reveal shared genetic and immune-related mechanisms, offering novel targets for cross-disease treatment strategies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
The JAK-STAT Signaling Pathway
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

